Search


Current filters:




Clear current filters  or Add more filters

View Option



Results 1-10 of 12 (Search time: 0.087 seconds).

  Necrotizing vasculitis in Greece: clinical, immunological and immunogenetic aspects. A study of 66 patients (Journal article)

  Response and progression in recurrent malignant glioma (Journal article)

  Phase II study of docetaxel-vinorelbine in platinum-resistant, paclitaxel-pretreated ovarian cancer (Journal article)

  Treatment of recurrent malignant gliomas with high-dose 13-cis-retinoic acid (Journal article)

  Paclitaxel (175 mg/m2) plus carboplatin (6 AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6 AUC) in advanced non-small-cell lung cancer (NSCLC): a multicenter randomized trial. Hellenic Cooperative Oncology Group (HeCOG) (Journal article)

  Intensive chemotherapy with high-dose epirubicin every 2 weeks and prophylactic administration of filgrastim in advanced breast cancer (Journal article)

  Glufosfamide administered using a 1-hour infusion given as first-line treatment for advanced pancreatic cancer. A phase II trial of the EORTC-new drug development group (Journal article)

  'Classical' but not 'other' mutations of EGFR kinase domain are associated with clinical outcome in gefitinib-treated patients with non-small cell lung cancer (Journal article)

  C-Met overexpression in node-positive breast cancer identifies patients with poor clinical outcome independent of Her2/neu (Journal article)

  Dose-dense sequential chemotherapy with epirubicin and paclitaxel versus the combination, as first-line chemotherapy, in advanced breast cancer: a randomized study conducted by the Hellenic Cooperative Oncology Group (Journal article)